Cannapharm’s medical cannabis:

Known for over 10,000 years for its many uses as a source of fiber, food and medicinal plant, Cannabis sativa is experiencing a renaissance in the medical world thanks to Cannapharm AG.

We are committed to re-establishing cannabis and its preparations as an integral part of the natural medicinal treasure trove. We rely on cultivation by Swiss farmers to place cannabis among other medicinal plants.

Cannapharm AG produces cannabis-based starting products for the manufacture of medicines and cannabis extracts for the specialist trade with the utmost care. These are produced in accordance with the current GMP guidelines and are grown and manufactured in Switzerland. With over 10 years of experience on the Swiss market, Cannapharm AG guarantees the highest quality and reliability.

Our company


Founded in 1999 by Markus Lüdi, the family business is now also co-managed by Karin Lüdi. Cannapharm AG is a pioneer in the production of cannabis extracts and has been represented with products on the Swiss market since 2012. The company remains true to its values, even under cross-generational management: top product quality, reliability, fairness and commitment.

Markus Lüdi

CEO FvP

Karin Lüdi

Marketing